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Abstract: Congenital hereditary endothelial dystrophy (CHED), presents in infancy or early 
childhood with bilateral clouding of corneas. This condition has previously been managed sur-
gically with penetrating keratoplasty (PKP). Performing PKP in pediatric patients has its own 
set of difficulties. More recently, there has been growing interest in treating this condition with 
Descemet’s stripping automated endothelial keratoplasty (DSAEK). The purpose of this study 
is to report our experience of successfully performing DSAEK in a child with CHED.
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Introduction
Congenital hereditary endothelial dystrophy (CHED) is a corneal dystrophy character-
ized by bilateral diffuse clouding of the corneas, causing impaired vision. Depending 
on the mode of inheritance, it manifests either in infancy or young childhood with a 
cloudy cornea, light sensitivity, tearing, and sometimes nystagmus.1
CHED is primarily a disease of the corneal endothelium, but it has traditionally been 
treated with penetrating keratoplasty.2 Targeted corneal endothelium transplantation 
techniques, such as Descemet’s stripping automated endothelial keratoplasty (DSAEK), 
have become a standard of care for the treatment of corneal endothelial dysfunction in 
adults,3 but few reports exist describing its use in the pediatric age group.4–7
In this report, the authors describe a case of DSAEK being performed in a child 
with CHED.
Case report
A 10-year-old boy presented to the Corneal and Refractive Surgery Unit as a referral 
from a local ophthalmologist due to poor vision and hazy corneas since infancy. There 
was a positive family history of the condition. The father and both of the child’s siblings 
were affected by the same condition. A diagnosis of CHED was made on the basis of 
clinical findings and the positive family history.
Visual acuities were counting fingers at 1 m in both eyes. Examination showed 
uniplanar, jerky, horizontal nystagmus. The corneas of both eyes were diffusely 
edematous (Figure 1), with central corneal thicknesses of 921 µm and 891 µm in the 
right and left eyes respectively, measured with ultrasonic pachymetry. Intraocular 
pressures were 15 mmHg in the right eye and 18 mmHg in the left eye. The horizontal 
corneal diameters were normal in both eyes. The edematous corneas obscured details 
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of the fundus on dilated examination. Endothelial cell counts 
and specular microscopy were not possible due to the corneal 
edema. Axial lengths of the eyes were slightly shorter than 
normal, being 22.53 mm and 22.49 mm, as confirmed on 
A-scan ultrasound biometry.
The patient was scheduled for DSAEK on the right eye, 
to be performed under general anesthesia. To assist in graft 
sizing, the eye was measured with a pair of calipers at the 
beginning of the procedure and was found to be 10.5 mm. The 
endothelial graft was prepared using a Moria CB microker-
atome head (350 µm blade depth) and a Moria ALTK artificial 
(AC) anterior chamber (Moria Surgical, Doylestown, PA). 
The thickness of the donor cornea was 673 µm, as measured 
by ultrasonic pachymetry. After the microkeratome pass, the 
posterior lamella tissue was punched from the endothelial side 
using a disposable trephine, 8 mm in diameter. The thickness 
of the posterior lamella was measured to be 138 µm. The 
donor tissue was then covered with Optisol solution (Chiron 
Ophthalmics, Irvine, CA) until use.
With the surgeon sitting temporally, the central corneal 
epithelium was debrided to improve visualization of the AC 
(Figure 2A). A 1-mm side port was created at the 6 o’clock 
position, through which an AC maintainer was inserted and 
the irrigating fluid turned on. A 2.75-mm temporal clear 
corneal incision was created, through which Descemet’s 
membrane (DM) scouring was performed at the required 
diameter using a reverse Sinskey hook (Figure 2B). The AC 
maintainer was then turned off, and Trypan blue dye was 
injected into the AC. The AC maintainer was then turned 
back on to wash the dye out of the AC. A 90° Descemet’s 
stripper was then used to strip DM from the overlying cor-
neal stroma (Figure 2C). Stripping of DM was difficult and 
detachment did not occur even after numerous attempts. 
DM was therefore left in place. A peripheral iridectomy 
was performed at the 11 o’clock position using a vitrector 
(Figure 2D). A 4.5-mm sized nasal clear corneal incision 
was created to prepare for insertion of the tip of the Busin 
glide (Moria Surgical).8,9
The donor disk was transferred to the Busin glide with the 
endothelial surface oriented upwards. The central area of the 
endothelium was coated with viscoelastic, taking care not to 
let viscoelastic reach the stromal side of the graft.
With the surgeon sitting superiorly, the loaded glide was 
inverted and positioned at the entrance of the nasal clear 
corneal incision. Busin forceps were then passed through 
the temporal incision across the AC to grasp the donor disk 
at the glide opening. The donor disk was pulled into the AC 
(Figure 2E) and allowed to unfold spontaneously under con-
tinuous irrigation from the AC maintainer (Figure 2F). An air 
bubble was injected under the graft and the AC maintainer 
was turned off (Figure 2G). The wound was then secured 
with 10/0 nylon monofilament sutures.
The epithelial surface was then gently massaged using 
a blunt, bent, irrigating cannula centered on the disk 
(  Figure 2H). After centration was achieved, a large air 
bubble was injected into the AC to keep the disc adherent 
to the overlying stroma for around 15 minutes (Figure 3). 
At the conclusion of the procedure, some air was exchanged 
with balanced salt saline (BSS), reducing the bubble size to 
approximately 2/3rd of the AC volume.
Postoperatively, the patient was positioned in a face-up 
position for the first 3 to 4 days. Medication consisted of 
topical Moxifloxacin HCl 0.5% four times daily (Vigamox. 
Alcon, Fort Worth, TX) and 1% Prednisolone acetate suspen-
sion (Pred Forte®, Allergan, Irvine, CA) administered hourly 
for the first week. Medications were tapered as appropriate 
through the postoperative period. Sutures were removed at 
the slit lamp after 2 months. No examination under anesthesia 
was required during the postoperative course.
Best spectacle corrected visual acuity (BSCVA) at 
3 months was 20/400. At 1 year, the patient had BSCVA 
of 20/100 with a refraction of +4 − 0.5 × 180, and was 
able to play s  occer at school with this vision. Vision in 
the left eye remained at counting fingers. The corneal 
stroma, although it became clearer, did not become totally 
  transparent, with   moderate residual stromal haze being 
  present even at 1 year while the central corneal thickness 
was 658 µm (Figure 4A – postoperative appearance at 
2 weeks;   Figure 4B – appearance at 1 month   postoperatively; 
  Figure 4C – postoperative appearance at 3 months; 
Figure 4D – postoperative appearance at 1 year).
Figure 1 Preoperative appearance of right eye of patient. Best corrected visual 
acuity counting fingers at 1 m.
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Figure 2 (A) intraoperative view of cornea after debridement of corneal epithelium; (B) scouring of Descemet’s membrane using a reverse Sinskey hook; (C) stripping of 
Descemet’s membrane from the overlying corneal stroma with a 90° Descemet’s stripper; (D) performing a peripheral iridectomy with a vitrector; (E) pulling the endothelial 
graft into the anterior chamber; (F) unfolding of the graft in anterior chamber; (G) an air bubble is injected under the graft; (H) centration of the donor disc by massaging 
the epithelial surface of the cornea with an irrigating cannula.
Discussion
Corneal transplantation in children is a challenging task. 
Conventional penetrating keratoplasty has a higher risk 
of graft failure and poorer visual prognosis than that of 
adult keratoplasty. Children are harder to examine, their 
eyes have low scleral rigidity, and produce more of a 
fibrin reaction. During surgery, positive vitreous pressure 
may be ex  perienced. There is an increased risk of infection 
and rejection due to sutures loosening frequently, necessitat-
ing their early replacement or removal. PKP wounds are more 
prone to traumatic rupture in children than in adults.10
Targeted endothelial keratoplasty now forms an accepted 
standard of care for corneal endothelial dysfunction in adults.3 
The benefits that endothelial transplantation procedures 
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Figure 4 (A) postoperative appearance at 2 weeks; (B) postoperative appearance at 1 month; (C) postoperative appearance at 3 months; (D) postoperative appearance 
at 1 year.
such as DSAEK have over conventional PKP include faster 
visual rehabilitation, fewer or no sutures, and a structurally 
stronger globe. These benefits are especially desirable in the 
pediatric age group. To date, however, reports of DSAEK 
being performed in children are few in number, with varying 
degrees of success, with some being successful and others 
being converted to PKP.
While performing DSAEK in both cases, we found 
that the AC view was poor due to the corneal edema. 
De  briding the corneal epithelium did little to improve v  isibility 
during the procedure. It was not possible to remove Descemet’s 
membrane in this case. Movement inside the eye was made 
d  ifficult by the shallow AC and phakic state of the eye (Fi  gure 1). 
Other authors have also reported these findings. Pineda et al, 
attempted to perform DSAEK on an eye with CHED, but the 
procedure was converted to a PKP due to difficulty in detach-
ing Descemet’s membrane and poor clarity of the cornea.4 
In contrast, the case the authors performed was successfully 
completed in spite of an inability to remove DM. Studies have 
shown, however, that retention of DM in the donor–recipient 
interface can predispose to graft failure in DSAEK.11
As the photos show, the time taken for the corneal 
stroma to clear after surgery was prolonged (Figure 4A–D). 
The c  orneal stroma retained some anterior haze for 
up to 1 year after s  urgery (Figure 5A – appearance of 
corneal stroma at 3 months; Fi  gure 5B – appearance of corneal 
stroma at 6 months; Figure 5C – appearance of corneal stroma 
at 1 year). This haze was mainly located in the AC stroma.
The final BCVA reached by this patient was 20/100. This 
suboptimal outcome may have been due to the persistent 
stromal haze or the coexistent amblyopia due to hyperopia. 
Had surgery been performed in a younger patient, there might 
have been less corneal haze and more potential for treating 
Figure 3 Injection of a large air bubble into the anterior chamber at the conclusion 
of the procedure.
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Figure 5 (A) cross sectional appearance of corneal stroma at 3 months; (B) cross sectional appearance of corneal stroma at 6 months; (C) cross sectional appearance of 
corneal stroma at 1 year.
the amblyopia. Other recent reports describe DSAEK being 
performed for CHED in babies as young as 6 months12 and 
neonates.13 These cases could potentially reach better levels 
of vision as there is sufficient time to treat any associated 
amblyopia.
No examinations under anesthesia were required in this 
case, as the child was cooperative enough to have his sutures 
removed at the slit lamp. This is in contrast to pediatric PKP, 
where multiple hospital admissions are usually needed during 
the postoperative course. Moreover, as the final refraction 
showed in this child, the procedure was refractively neutral, 
due to the absence of sutures.
In conclusion, DSAEK can be used successfully in the 
treatment of CHED in children, as an alternative to PKP. 
DSAEK allows for a more rapid visual rehabilitation of 
patients and fewer subsequent postoperative hospital admis-
sions for treatment. However, proper timing of the surgery 
is important to attain a good outcome.
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